Something else caught my eye.
1) In their final results, the authors reference a baseline dataset before cohort swapping because their reference numbers are 49 and 51. Whatever the case, those are not the numbers of patients that began LP and SMC sessions. They must have known this to misrepresent the situation when writing the paper.
The weird thing is it looks like they did not use the secondary baseline characteristics, but the ones immediately following randomization.
2) There is a leapfrogging of cohorts between baseline and follow-up point 1 in figure 2. SMC starts out higher, but then quickly SMC+LP is higher. This represents the largest change from the interventions. We know baseline is again a misrepresentation, because the numbers are again 49 and 51. So, the cohort dropout took place before baseline and first follow-up.
So, the authors used the baseline immediately after randomization, not after the patients switched cohorts. It doesn't represent the baseline before the actual trials began.
But they knew this couldn't be accurate
Instead they labelled them as "not followed up on" which implies they were unfilled questionnaires. They also, I think shockingly, left this out of the text. This info can only be found in the supplementary data and the info about the phone call is from the feasability trial.
Amazing sleuth work. Thank you for succinctly highlighting the slipperyness of it all. Surely retraction is the only option open now?
@dave30th, @Jonathan Edwards,@Carolyn Wilshire